S. aureus is a major human pathogen of the respiratory tract that activates the type I & III interferon (IFN) cascades. Influenza virus also activates a significant IFN response and significantly increases the susceptibility to secondary S. aureus infection in the lung. Although much is known about the role of IFNs and influenza co-infection in the lung, much less is known about the role of influenza infection and the role the host response plays to S. aureus colonization of the upper airway. Bacteria aspirated from the upper respiratory tract leads to pneumonia and activation of IFN signaling in the lung, contributing to infection and pulmonary pathology. In the experiments proposed we will establish the role of IFN signaling in colonization (bacterial burden in the nasopharynx) of S. aureus in the upper respiratory tract and the influence of influenza infection on colonization, investigating bot the microbial and host factors involved. We will determine the effect IFN signaling has on immune cell function and the ability of influenza neuraminidase to provide an environment conducive to colonization. This work will be accomplished using wild-type and knockout mice in murine models of nasal colonization and acute pneumonia. S. aureus targets human immune cells, therefore pathology due to immune cell recruitment and function will be documented in a novel humanized mouse model of S. aureus infection. In the context of influenza we will address two questions: does influenza increase susceptibility to colonization, and in already colonized hosts does influenza cause increased bacterial burden and secondary pneumonia. We will complement in vivo studies with in vitro tissue culture, adherence and biofilm assays. We will also test approved drugs in an attempt to reduce levels of S. aureus colonization. Given the limited efficacy of currently available antibiotics in the setting of MRSA infection, these studies have potential applications for immunomodulary therapy and decolonization strategies to reduce infection rates and vastly improve patient outcome.
The first step in S. aureus infection is colonization of the nose. This proposal will determine the role of interferon signaling in colonization and the influence influenza infection has on colonization and subsequent infection of the lung. The mechanisms behind increased susceptibility post-influenza will be investigated and interference strategies employed to reduce nasal density and secondary pneumonia of S. aureus. These studies will provide a potential target for therapeutic intervention.
Parker, Dane (2018) CD80/CD86 signaling contributes to the proinflammatory response of Staphylococcus aureus in the airway. Cytokine 107:130-136 |
Parker, Dane (2017) Impact of Type I and III Interferons on Respiratory Superinfections Due to Multidrug-Resistant Pathogens. J Infect Dis 215:S58-S63 |
Parker, Dane; Prince, Alice (2016) Immunoregulatory effects of necroptosis in bacterial infections. Cytokine 88:274-275 |
Planet, Paul J; Parker, Dane; Cohen, Taylor S et al. (2016) Lambda Interferon Restructures the Nasal Microbiome and Increases Susceptibility to Staphylococcus aureus Superinfection. MBio 7:e01939-15 |
Cohen, Taylor S; Parker, Dane (2016) Microbial pathogenesis and type III interferons. Cytokine Growth Factor Rev 29:45-51 |